Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-02-23
1997-04-29
Draper, Garnette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530350, 530351, 530395, 530397, 530402, 5303917, 435174, C07K 200, C07K 1443, C07K 14505, A61K 3802
Patent
active
056250355
ABSTRACT:
Purified mammalian erythropoietin binding-protein is disclosed, and its isolation, identification, characterization, purification, and immunoassay are described. The erythropoietin binding protein can be used for regulation of erythropoiesis by regulating levels and half-life of erythropoietin. A diagnostic kit for determination of level of erythropoietin binding protein is also described.
REFERENCES:
patent: 4558006 (1985-12-01), Egrie
patent: 5378808 (1995-01-01), D'Andrea et al.
D'Andrea, A. D., et al., (1989) Cell 57: 277-85.
Blum, W.F., et al., (1989) Endocrinol. 125: 766-792.
Todokero, et al. (Oct. 5, 1991) Gene 106: 283-4.
Metzler, D.M. (1977) Biochemistry, New York: Academic Press, p. 374.
Takahashi, T., et al. (1995) Blood 85(1): 106-114.
J. Garcia and G. Clemons, Recent Advances in Nuclear Medicine, The Radioimmunoassay of Erychropoietin, vol. 6, pp. 19-31, (1983).
A. Besarab, Am. J. Nephrol, Recombinant Human Erythropoeitin: Physiology of Anemia in Renal Failure and Economic Aspects Related to Dosing, 10 (suppl 2) pp. 2-6, (1990).
B. Varet, N. Casadevall, C. Lacombe, P. Nayeaux, Erythropoeitin: Physiology and Clinical Experience, Seminars in Hematology, vol. 27: (Suppl. 3), pp. 25-31, (Jul. 1990).
D. Bowen, B. Ehmer, P. Neubert, T. Lewis, and A. Jacobs, The Clearance of a Single i.v., Bolus of Recombinant Human Erythropoeitin from the Serum of Patients with Myelodysplastic Syndromes and Its Effects on Erythropoiesis, Experimental Hematology, 19:613-616 (1991).
R. Abels and S. Rudrick, Erythropoietin: Evolving Clinical Applications, Experimental Hematology: 19:842-850 (1991).
J. George, C. Bracco, K. Shannon, G. Davis, L. Smith, R. Phibbs, and A. Hendrickx, Age-Related Differences in Erythropoietic Response to Recombinant Human Erythropoietin: Comparison in Adult and Infant Rhesus Monkeys Pediatric Research, vol. 28:6, pp. 567-571, (1990).
K. Shannon, Recombinant Erythopoietin in Pediatrics: A Clinical Perspective, Pediatric Annals, 19:197-206 (1990).
J. Eschbach and J. Adamson, Recombinant Human Erythropoietin: Implications for Nephrology, American Journal of Kidney Diseases, vol. 11:3, pp. 203-209, (Mar. 1988).
Bon Kathleen Dal
Draper Garnette D.
Fitzgerald David L.
Martin Paul R.
Ross Pepi
LandOfFree
Erythropoietin binding protein from mammalian serum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythropoietin binding protein from mammalian serum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin binding protein from mammalian serum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-706802